Oklahoma Mesothelioma Fact Sheet

While mesothelioma is a problem in all states, the specific incident rate for Oklahoma is 0.8 / 100,000. This is below the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in OK, recent OK mesothelioma-related court cases, mesothelioma specialists in OK and potential asbestos hotspots in Oklahoma.

[doptabs]
[doptab title=”Overview”]

Oklahoma Mesothelioma Info

By clicking on the above tabs, you will find information on mesothelioma specific to the state of Oklahoma

Oklahoma Research and Clinical Trials

This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.

Oklahoma Doctors and Hospitals

This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.

Oklahoma Cases

This is a partial list of relevant court cases on mesothelioma in your state.

Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.

[/doptab]
[doptab title=”Treatment and Research”]

Research

Clinical Trials

[dopaccordions]
[dopaccordion title=”Completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung” icon=27 activeicon=28]

Condition: Malignant Mesothelioma

Intervention: Drug: erlotinib hydrochloride

More Information

[/dopaccordion]
[dopaccordion title=”Active, not recruiting Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: cisplatin; Drug: gemcitabine hydrochloride
More Information

[/dopaccordion]
[dopaccordion title=”Active, not recruiting PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
More Information

[/dopaccordion]

[dopaccordion title=”Recruiting Collecting Tumor Samples From Patients With Gynecological Tumors” icon=27 activeicon=28]

Condition: Cancer
Intervention: Other: biologic sample preservation procedure
More Information

[/dopaccordion]

[/dopaccordions]
[/doptab]
[doptab title=”Doctors and Hospital”]

Hospitals and Cancer Centers

CCOP-Sooner State

6151 S. Yale #100
Tulsa, OK
918.499.2000

[/doptab]
[doptab title=”Cases”]

Zinc Corp. of Am. v. Reeder
Case Number: 103182, COURT OF CIVIL APPEALS OF OKLAHOMA, DIVISION TWO, March 28, 2007, Decided, July 19, 2007, Mandate Issued

Fautheree v. McCaffrey
No. 101,051 , COURT OF CIVIL APPEALS OF OKLAHOMA, DIVISION THREE, August 4, 2005, Decided , August 24, 2006, Mandate Issued

[/doptab]
[doptab title=”Lawyers”]

If you would like information on how to see the published ratings for different mesothelioma lawyers and law firms, please fill-in the form below:

  • This field is for validation purposes and should be left unchanged.

[/doptab]
[/doptabs]